SCHEMBL14419982

SCHEMBL14419982

O=CCCOc1ccc2c(c1)/C(=C/CCN1CCC(O)(c3ccc(Cl)cc3)CC1)c1cccnc1CO2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 4/20 0.59
CHRM2 P08172 1/20 0.49
CCR5 P51681 1/20 0.49
DRD2 P14416 6/20 0.42
DRD3 P35462 3/20 0.42
HRH1 P35367 2/20 0.42
HTR1A P08908 1/20 0.42
DRD1 P21728 1/20 0.42
DRD5 P21918 1/20 0.42
SLC6A2 P23975 1/20 0.42
HTR2A P28223 1/20 0.42
SLC6A4 P31645 1/20 0.42
HTR7 P34969 1/20 0.42
HTR2B P41595 1/20 0.42
SIGMAR1 Q99720 1/20 0.40
DRD4 P21917 1/20 0.39
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13824393 0.94 CCR1 (0.59) CCR1CHRM2CCR5DRD2DRD3
SCHEMBL7211475 0.93 CCR1 (0.59) CCR1CHRM2CCR5DRD2DRD3
SCHEMBL7211479 0.93 CCR1 (0.59) CCR1CHRM2CCR5DRD2DRD3
SCHEMBL14419951 0.93 CCR1 (0.59) CCR1CHRM2CCR5DRD2DRD3
SCHEMBL10288251 0.93 CCR1 (0.60) CCR1CHRM2CCR5DRD2DRD3
SCHEMBL13620889 0.93 CCR1 (0.60) CCR1CHRM2CCR5DRD2DRD3
SCHEMBL10287610 0.93 CCR1 (0.60) CCR1CHRM2CCR5DRD2DRD3
SCHEMBL14419984 0.92 CCR1 (0.57) CCR1CHRM2CCR5DRD2DRD3
SCHEMBL7210692 0.92 CCR1 (0.58) CCR1CHRM2CCR5DRD2DRD3
SCHEMBL7206227 0.92 CCR1 (0.58) CCR1CHRM2CCR5DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7271176-B2 Chemokine receptor antagonists and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2007-09-18 US disclosed